• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kirby McInerney LLP Reminds Global Cord Blood Corporation (CORBF) Investors of Upcoming Deadline in Class Action Filing

By: Kirby McInerney LLP via GlobeNewswire
June 03, 2024 at 11:11 AM EDT

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Global Cord Blood Corporation (“Global Cord” or the “Company”) (OTC: CORBF) securities during the period of June 4, 2019 through May 3, 2022, inclusive (“the Class Period”). Investors have until June 24, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

[Click here to learn more about the class action]

On April 29, 2022, Global Cord Blood Corporation announced a transaction through a Form 6-K filing with the U.S. Securities and Exchange Commission (SEC), disclosing its decision to acquire biotechnology company Cellenkos for over $1 billion. The deal included $664 million in cash and 114 million Global Cord shares, effectively diluting existing shareholders by half and significantly reducing the Company’s cash reserves. On this news, the price of Global Cord shares declined by $0.98 per share, or approximately 28.6%, from $3.43 on April 29, 2022 to $2.45 on May 2, 2022.

On May 3, 2022, Blue Ocean Structure Investment Company Limited filed a Petition in the Grand Court of the Cayman Islands, opposing the acquisition of Cellenkos. The Petition raised concerns about Cellenkos’ long-term value, the unjustifiable purchase price, massive shareholder dilution, conflicts of interest, and insufficient shareholder awareness. On this news, the price of Global Cord shares declined by $0.22 per share, or approximately 9.1%, to close at $2.20 per share on May 5, 2022.

The lawsuit alleges that Global Cord made false and/or misleading statements and/or failed to disclose that: (1) Global Cord employed a capital allocation strategy designed to reserve funds for Company insiders and related parties rather than for the benefit of Company shareholders; (2) Global Cord’s decisions to reject multiple going private offers and enter into the Transaction were nothing more than self-serving and conflicted attempts to divert company funds to corporate insiders and related parties; and (3) the Company had fundamentally misrepresented to investors Global Cord’s approach to capital allocation, strategic investments, acquisitions, and related party transactions as a result of misappropriation.

If you purchased or otherwise acquired Global Cord securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this CONTACT FORM, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts
Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com


Primary Logo

More News

View More
Will Hims & Hers Fall Along With Novo Nordisk?
Today 17:07 EDT
Via MarketBeat
Tickers HIMS NVO
Play It Cool: Why Comfort Systems USA Is a Hidden AI Winner
Today 15:21 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers FIX META MSFT NVDA
Rocket Lab Reports Next Week: Here’s What Investors Should Know
Today 10:49 EDT
Via MarketBeat
Tickers RKLB
Apple Stock: Big Earnings, Small Move—Time to Buy?
Today 9:25 EDT
Via MarketBeat
Tickers AAPL META MSFT
Amazon's Earnings: What Comes Next and How to Play It
Today 9:10 EDT
Via MarketBeat
Tickers AMZN
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap